- Home
- GDRX vs JANX Comparison
GDRX vs JANX Comparison
Compare GDRX & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDRX | JANX |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | United States |
| Employees | 738 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 868.9M | 890.8M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GDRX | JANX |
|---|---|---|
| Price | $2.52 | $14.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $4.78 | ★ $57.36 |
| AVG Volume (30 Days) | ★ 2.1M | 1.8M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $800,651,000.00 | $10,000,000.00 |
| Revenue This Year | $2.30 | N/A |
| Revenue Next Year | $2.63 | N/A |
| P/E Ratio | $29.60 | ★ N/A |
| Revenue Growth | ★ 1.30 | N/A |
| 52 Week Low | $2.47 | $12.80 |
| 52 Week High | $5.81 | $47.58 |
Technical Indicators
Market Signals| Indicator | GDRX | JANX |
|---|---|---|
| Relative Strength Index (RSI) | 31.70 | 46.56 |
| Support Level | $2.47 | $12.80 |
| Resistance Level | $2.63 | $15.49 |
| Average True Range (ATR) | 0.11 | 0.63 |
| MACD | -0.02 | 0.48 |
| Stochastic Oscillator | 11.23 | 72.49 |
Price Performance
Historical ComparisonAbout GDRX GoodRx Holdings Inc.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.